Note 7 – License Agreements

We have entered into license agreements which allow us to develop, manufacture, and/or commercialize the following drug assets:

Schedule of License Agreements 

Under these agreements, we have certain development and regulatory milestone payments payable to each licensor. As of December 31, 2025, no amounts are owed under the license agreements.